Behavior abnormality following intraveno
β
Sepide Saroukhani; Asghar Aghamohammadi; Javad Mahmoudi-Gharaei; Hassan Abolhass
π
Article
π
2010
π
John Wiley and Sons
π
English
β 122 KB
## Abstract ## Objective Treatment with intravenous immunoglobulin (IVIG) is considered a safe therapy for patients with primary antibody deficiencies (PADs), whilst adverse effects have been frequently reported. Meantime behavioral disorders reactions have not been reported yet. In this study, we